PPD Comprehensive Review Will Examine Resource Allocation
This article was originally published in The Pink Sheet Daily
Each division of the CRO will submit a report by the end of July on how to achieve “consistent operating excellence.” CEO Eshelman says changes could be significant or “little tweaks.”
You may also be interested in...
PPD plans to maintain its dual structure of providing discovery sciences and development services, at least for the near term, CEO Fred Eshelman said Dec. 14
Pink Sheet reporters and editor discuss the influence of the emergency use authorization on FDA decisions, another twist in the march-in rights debate, and how CBER is not using the real-time oncology review program.